# Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease

> **NCT02542319** · PHASE2 · COMPLETED · sponsor: **Nordsjaellands Hospital** · enrollment: 148 (actual)

## Conditions studied

- Chronic Kidney Disease
- Vascular Calcification
- Uremic Osteodystrophy

## Interventions

- **DIETARY_SUPPLEMENT:** Mablet 360 mg
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02542319
- **Lead sponsor:** Nordsjaellands Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2020-11
- **Final completion:** 2021-07
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2022-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02542319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02542319, "Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02542319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*